ArticleBMC infectious diseases2025
Post-COVID-19 subacute painless thyroiditis: a case report in an anabolic androgenic steroid user.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- How to manage subacute thyroiditis.Drugs in context · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe coronavirus disease of 2019 is still a serious clinical problem. Moreover, its course is now often subclinical or asymptomatic. However, it may lead to the development of diseases of other organs, including thyroid diseases. One of them is subacute thyroiditis. The pathophysiology of this disease is poorly understood. Although it is typically painful, it can also be painless, but these cases are rare. In the cases without neck pain, general symptoms are often mild, which means that it can be insidious and manifest itself primarily as limited exercise capacity. The purpose of the paper is to describe the clinical course of the disease on the basis of a clinical case, to review the literature on subacute thyroiditis after coronavirus disease of 2019 in adults and to summarize the current state of knowledge about this disease. CASE PRESENTATION: We present here the case of a 31-year-old amateur weightlifter who developed mild, self-limiting hyperthyroidism after being infected with severe acute respiratory syndrome coronavirus 2. Thyroid ultrasound revealed no abnormalities. At week 17 postinfection, TSH was 0.0016 mIU/L (0.27-4.2), and at week 19, TSH was 0.019 mIU/L with normal FT4 and FT3 values. Autoimmune thyroid disease was ruled out. Thyroid scintigraphy and biopsy were not performed due to the patient's delayed referral to an endocrinologist and the return of thyroid function to normal. Although the diagnosis of subacute thyroiditis was not clearly confirmed, the clinical course supports this diagnosis. The presented clinical case is particularly interesting because the limited endurance caused by this disease prompted him to use anabolic-androgenic steroids (oxandrolone and testosterone enanthate), which significantly hampered the interpretation of the results. We also summarize the current state of knowledge about subacute thyroiditis after coronavirus disease of 2019 and discuss the impact of the use of anabolic-androgenic steroids on thyroid function and laboratory test results.
conclusionsThis case highlights the need to consider subacute thyroiditis in patients with unexplained thyrotoxicosis after COVID-19, especially when confounding factors, such as anabolic steroid use, are present.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.